|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1800657218 |
| 003 |
DE-627 |
| 005 |
20250619202118.0 |
| 007 |
tu |
| 008 |
220502s2022 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1800657218
|
| 035 |
|
|
|a (DE-599)KXP1800657218
|
| 035 |
|
|
|a (OCoLC)1313522625
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
|
|a 616.994
|q DE-101
|
| 082 |
0 |
4 |
|a 610
|a 570
|q DE-101
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.81
|2 bkl
|
| 100 |
1 |
|
|a Hägele, Tanja
|d 1991-
|e VerfasserIn
|0 (DE-588)1213369878
|0 (DE-627)1713914751
|4 aut
|
| 245 |
1 |
0 |
|a Preclinical evaluation of the multikinase inhibitor regorafenib for the treatment of pancreatic cancer
|c presented by M. Sc. Tanja Hägele ; referees: Prof. Dr. Rienk Offringa, Prof. Dr. Dr. Amir Abdollahi
|
| 264 |
|
1 |
|a Heidelberg
|c [2022]
|
| 300 |
|
|
|a XVII, 205 Seiten
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Enthält 3 Zeitschriftenaufsätze
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-University Heidelberg
|d 2022
|
| 546 |
|
|
|a Text Englisch, Zusammenfassung in englischer und deutscher Sprache
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|c 20250619
|f FID
|f DE-2298
|x XA-DE-NI
|z FID Pharmazie
|2 pdager
|5 DE-84
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Offringa, Rienk
|e AkademischeR BetreuerIn
|0 (DE-588)1066807485
|0 (DE-627)817963391
|0 (DE-576)426161424
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 856 |
4 |
2 |
|u https://www.gbv.de/dms/bs/toc/1800657218.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|v 2024-02-06
|3 Inhaltsverzeichnis
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
| 936 |
b |
k |
|a 44.81
|j Onkologie
|0 (DE-627)106409433
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20220504
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2022
|
| 998 |
|
|
|g 1213369878
|a Hägele, Tanja
|m 1213369878:Hägele, Tanja
|d 140000
|d 140001
|e 140000PH1213369878
|e 140001PH1213369878
|k 0/140000/
|k 1/140000/140001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1800657218
|e 4128967211
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"physDesc":[{"extent":"XVII, 205 Seiten","noteIll":"Illustrationen, Diagramme"}],"noteThesis":["Dissertation. - Ruprecht-Karls-University Heidelberg. - 2022"],"recId":"1800657218","language":["eng"],"type":{"bibl":"thesis"},"note":["Enthält 3 Zeitschriftenaufsätze"],"id":{"eki":["1800657218"]},"title":[{"title_sort":"Preclinical evaluation of the multikinase inhibitor regorafenib for the treatment of pancreatic cancer","title":"Preclinical evaluation of the multikinase inhibitor regorafenib for the treatment of pancreatic cancer"}],"corporate":[{"display":"Universität Heidelberg","role":"dgg"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"[2022]","publisherPlace":"Heidelberg"}],"name":{"displayForm":["presented by M. Sc. Tanja Hägele ; referees: Prof. Dr. Rienk Offringa, Prof. Dr. Dr. Amir Abdollahi"]},"person":[{"display":"Hägele, Tanja","family":"Hägele","given":"Tanja","role":"aut"},{"display":"Offringa, Rienk","family":"Offringa","role":"dgs","given":"Rienk"}]}
|
| SRT |
|
|
|a HAEGELETANPRECLINICA2022
|
